Walkthrough Wednesdays | Meet Context-Aware Onboarding Because onboarding shouldn’t feel like paperwork. It should feel like progress. Watch how Arclio learns who you are, pulls your data, and suggests automations that actually make sense — all in under two minutes. #WalkthroughWednesdays #AIOrchestration #Onboarding #Automation #EnterpriseAI #Arclio #Demo #NYTech #NewYorkAI #AI #BuildInPublic #ContextAware

A presenter said the state has enacted a one-year moratorium on hyperscale data centers, signed the RAISE Act, and will require Frontier AI developers to register in November and meet transparency and incident-reporting standards beginning in January.

From prompt to dashboard in seconds. No templates. No developers. Just plain language — and the assistant handles the rest. We've been building something quietly. This is a small preview of where it's going. More coming soon! Start building at www.arclio.ai 🚀 #AI #ArtificialIntelligence #ProductDemo #Chatbot #AIAssistant #Dashboard #BuildWithAI #FutureOfWork #NoCode #Arclio #NYTech #NewYorkAI #Automation

The presenter said developers are planning lawsuits over the state's AI rules and openly invited legal challenges, saying, 'Bring it on.'

Tired of setting up the same context every time you open a chat? We just released a feature that fixes that — and once you see it, you'll wonder how you worked without it. 😉 Drop a comment if this is something your team needs. 👇 #ProductDevelopment #AI #Feedback #Workflow #Walkthrough #Demo #Chatbot #Arclio #NYTech #NewYorkAI #BuildingInPublic

Senator Andrew Gennardis, co-sponsor of the RAISE Act, said he has filed follow-up legislation to require independent third‑party audits of frontier models and to strengthen mandatory safety frameworks to better guard against catastrophic harms.

Meta has restructured its AI division for the FOURTH time in SIX months. The company is splitting into new units (superintelligence, consumer products, infrastructure, and research), hitting pause o...

We're building in public 🛠️ Here's a quick look at some of the features we've been working on for the Arclio Chatbot. We're continuously improving and adding more capabilities, so this is just a taste of what's to come. Would love to hear your thoughts! Stay tuned for more updates 👀 #ProductDevelopment #AI #Feedback #Workflow #Walkthrough #Demo #Chatbot #Arclio #NYTech #NewYorkAI #BuildingInPublic

Intelligence isn’t the challenge anymore—confidence is. Can you trust how your systems make decisions? If not, this article is for you. #AIOrchestration #EnterpriseAI #Automation #Governance #Transparency #BuildInPublic #Arclio #NYTech #NewYorkAI

📐 Arclio Blueprints | The Architecture of Confidence Enterprises don’t lose trust in AI because it’s inaccurate. They lose trust because it’s opaque. When systems act faster than teams can interpret, confidence erodes—not from failure, but from uncertainty. That’s why modern AI needs more than autonomy. It needs an architecture built for confidence. Orchestration provides that structure by linking three core pillars: 1️⃣ Context — Systems act with awareness of data, policies, history, and intent. 2️⃣ Governance — Rules, permissions, and compliance guardrails travel with every workflow. 3️⃣ Observability — Every automated action is visible, traceable, and explainable in real time. Together, these create an architecture where decisions aren’t just made, but understood. Confidence isn’t an outcome. It’s a design choice. And orchestration is how enterprises build it. See how orchestration builds trust into intelligent systems → www.arclio.ai #ArclioBlueprints #AIOrchestration #EnterpriseAI #SystemDesign #Governance #Observability #Automation #BuildInPublic #Arclio #NYTech #NewYorkAI

The governor announced he has signed the RAISE Act, which he said requires large AI developers to publish safety protocols, report critical incidents within 72 hours, and face potential civil penalties for noncompliance.

The governor announced he signed an executive order making New York the first state to impose a moratorium on hyperscale AI data centers, presented as part of state steps to manage AI risks in the absence of federal action.

The FDA’s comment window closes May 29. Before it does, it’s worth sitting with the specific question Section 2 is asking. If a regulator challenges an AI-generated insight in your submission, can you show them — independently, without relying on your own word — exactly how that insight was produced? Not an audit log. Not a narrative explanation. A structured record of every step: what data went in, what operations ran, what the model reasoned, and how each connects to the next. 21 CFR Part 11 gave clinical teams a framework for electronic records. Nothing equivalent exists yet for AI-generated analysis. That’s the gap Proof of Insight is trying to close — an open protocol, freely adoptable, built so clinical teams and regulators have a shared standard to point to. Working draft at www.proofofinsight.org. For those submitting AI-generated analysis today — what does your current validation process actually look like? #FDA #ClinicalTrials #RegulatoryAffairs #AIGovernance #ProofOfInsight #EnterpriseAI #OpenStandard #Arclio #NYTech #NewYorkAI #AI

The platform was configured carefully. The demo was clean. Months of professional services work went into the implementation. But 21 CFR Part 11 compliance isn't something you configure into a horizontal AI platform after the fact. It's an architectural decision made before the first line of code. When the FDA asks whether the system controlling access to that Phase II data meets electronic records and signature requirements — "we configured it carefully" is not a defensible answer. That's not a capability gap. That's a design gap. ✅ Use AI to query Phase II trial data. 🚩 Use a platform that isn't compliant by design to do it. What conditions would make this a green flag for you? Drop the reasoning below. See how Arclio is built for clinical trial infrastructure from the ground up at www.arclio.ai 🧪 #WouldYouAutomateThis #ClinicalTrials #21CFRPart11 #BiotechAI #WorkspaceCapsule #AIOrchestration #EnterpriseAI #Arclio #NYTech #NewYorkAI

More data sources used to mean more time, more people, more waiting. Watch what one sentence does instead.👇 #ClinicalTrials #TalkToData #LifeSciences #HealthcareAI #Arclio #NYTech #NewYorkAI #AI #Demo

This analysis used to take 2 days... Here is an example of our system being connected to a ficticious clinical trial data and you can ask complex question in plain English - no code, no analyst, no waiting.👇 #ClinicalTrials #TalkToData #LifeSciences #HealthcareAI #Arclio #AI #NewYorkAI #NYTech #Pharmaceutical #Biotechnology

Clinical trial teams are sitting on some of the most valuable data in the world — yet still waiting days for reports and relying on data engineers for every query. There's a better way. We built Talk to Data so teams can get answers in seconds, not days. No SQL. No bottlenecks. No missed insights. I made an in-depth demonstration to get you acquainted with this recent development of ours. Watch it below: Book your personalized walkthrough at www.arclio.ai 🤖 #ClinicalTrials #HealthcareAI #TalkToData #LifeSciences #DrugDevelopment #Arclio #Pharmaceuticals #AI #BioPharma #EnterpriseAI #BuildInPublic #AgenticAI #NYTech #NewYorkAI

Audit shows New York lacks comprehensive AI governance leading to significant risk exposure.